Business Context and Reporting Period
This Form 8-K is filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd) for the reporting period ending March 31, 2025. The registrant is an emerging growth company incorporated in Delaware, with common stock (KLTO) and warrants (KLTOW) listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status regarding Nasdaq listing requirements.
Material Changes and Events
- Nasdaq Compliance Extension: On March 31, 2025, the Nasdaq Hearing Panel granted the Company an extension until August 13, 2025, to regain compliance with Listing Rules 5450(b)(2)(C) (Minimum Market Value of Publicly Held Shares) and 5450(b)(2)(A) (Minimum Market Value of Listed Securities).
- Contingency: The extension is contingent upon the Company achieving scheduled milestones and notifying Nasdaq. Failure to meet these milestones may result in the revocation of the extension.
- Historical Context: The Company previously received delinquency notices on August 16, 2024, and a Delisting Notice on February 14, 2025, due to non-compliance with the aforementioned market value standards.
- Appeal Process: The Company successfully appealed the delisting determination on February 21, 2025, which stayed the suspension of its securities pending the Panel's decision on March 28, 2025.
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management has secured a temporary reprieve from delisting but must meet specific, undisclosed milestones by August 13, 2025, to maintain its Nasdaq listing.
Risks and Contingencies: The primary risk is the potential revocation of the extension if the Company fails to satisfy the required milestones within the prescribed timeframe, which could lead to delisting from The Nasdaq Global Markets.
Investor Verification Checklist
- Verify the specific milestones required by the Nasdaq Hearing Panel to maintain the extension through August 13, 2025.
- Monitor the Company's stock price and public float to assess progress toward the Minimum Market Value of Publicly Held Shares (MVPHS) and Minimum Market Value of Listed Securities (MVLS) requirements.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.
- Review future filings for updates on milestone achievement or further regulatory actions.